论文部分内容阅读
2011年11月14日,国家发改委官方网站发布公告,披露了对山东潍坊顺通医药公司和潍坊市华新医药贸易公司非法控制两种治疗高血压普通药品原材料的市场、
On November 14, 2011, the official website of the National Development and Reform Commission issued a public notice disclosing the illegal market control of two kinds of ordinary pharmaceutical raw materials for the treatment of hypertension in Shandong Weifang Shun Tong Pharmaceutical Company and Weifang Huaxin Pharmaceutical Trading Company.